Drug-Induced Hypertension

Endocrinol Metab Clin North Am. 2019 Dec;48(4):859-873. doi: 10.1016/j.ecl.2019.08.013. Epub 2019 Sep 17.

Abstract

Untoward side effects of pharmaceuticals can result in considerable morbidity and expense to the health care system. There is likely a sizable fraction of the hypertensive population with disease either induced or exacerbated by polypharmacy. The elevation of blood pressure in drug-induced hypertension occurs through a variety of mechanisms, most notably, sodium and fluid retention, activation of the renin-angiotensin-aldosterone system, alteration of vascular tone, or a combination of these pathways. Recognition of common medications causing drug-induced hypertension is important to effectively control blood pressure. The epidemiology, pathophysiology, and management of these agents are discussed.

Keywords: Drug-induced hypertension; Polypharmacy; Secondary hypertension.

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / adverse effects*
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Calcineurin Inhibitors / adverse effects*
  • Central Nervous System Stimulants / adverse effects*
  • Contraceptives, Oral, Hormonal / adverse effects*
  • Glucocorticoids / adverse effects*
  • Hematinics / adverse effects*
  • Humans
  • Hypertension / chemically induced*
  • Hypertension / therapy*
  • Polypharmacy*
  • Serotonin and Noradrenaline Reuptake Inhibitors / adverse effects*
  • Substance-Related Disorders / complications*

Substances

  • Angiogenesis Inhibitors
  • Anti-Inflammatory Agents, Non-Steroidal
  • Calcineurin Inhibitors
  • Central Nervous System Stimulants
  • Contraceptives, Oral, Hormonal
  • Glucocorticoids
  • Hematinics
  • Serotonin and Noradrenaline Reuptake Inhibitors